Litcius/Paper detail

Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

Auriane Lesieur, Xavier Thomas, Olivier Nibourel, Nicolas Boissel, Laurène Fenwarth, Stéphane de Botton, Élise Fournier, Karine Celli‐Lebras, Emmanuel Raffoux, Christian Récher, Juliette Lambert, Céline Berthon, Arnaud Pigneux, Raphaël Itzykson, Pascal Turlure, Cécile Pautas, Jacques Vargaftig, Claude Preudhomme, Hervé Dombret, Nicolas Duployez

2020Haematologica14 citationsDOIOpen Access PDF

Abstract

Not available.

Topics & Concepts

NPM1Minimal residual diseasePolymerase chain reactionMyeloid leukemiaMedicineResidualDigital polymerase chain reactionLeukemiaCancer researchInternal medicineBiologyGeneticsGeneKaryotypeComputer scienceAlgorithmChromosomeAcute Myeloid Leukemia ResearchAdvanced biosensing and bioanalysis techniquesAcute Lymphoblastic Leukemia research
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use | Litcius